Accessory Sets Syringes: 6ml syringe with a female luer with 15cm sealed SCD tubing, REF: RF-T15,...
FDA Device Recall #Z-1068-2024 — Class II — December 19, 2023
Recall Summary
| Recall Number | Z-1068-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 19, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | OriGen Biomedical, Inc. |
| Location | Austin, TX |
| Product Type | Devices |
| Quantity | 3613 Cases |
Product Description
Accessory Sets Syringes: 6ml syringe with a female luer with 15cm sealed SCD tubing, REF: RF-T15, and 60ml syringe on a female luer with 15cm sealed SCD tubing, REF: 15-RF60-T
Reason for Recall
Accessory sets contain a syringes not yet qualified for the accessory's intended purpose; due to design changes to the syringe barrels and a polypropylene resin change that resulted in loss of gamma compatibility, for accessory set syringes that were gamma sterilized, which resulted in yellowed syringes.
Distribution Pattern
US: FL, WA, NJ, MA, OH, CA, MD, TX, NE, ND OUS: GB, CA,NL,CH, PL, DE
Lot / Code Information
REF/UDI-DI/Lots: RF-T15/10816203020205/ V23277, V23278, V23639; 15-RF60-T/10816203020571/V23281
Other Recalls from OriGen Biomedical, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1409-2021 | Class III | Evolve Cell Culture Bags, part numbers: EV1000... | Jan 28, 2021 |
| Z-0318-2021 | Class II | 3/8" FloPump, 32mL, (Sterile), REF 6400S, UDI: ... | Jun 24, 2019 |
| Z-0180-2019 | Class II | Reinforced Dual Lumen Cannula, 16Fr., REF: VV16... | Aug 21, 2018 |
| Z-0182-2019 | Class II | Reinforced Dual Lumen Cannula, 23Fr., REF: VV23... | Aug 21, 2018 |
| Z-0179-2019 | Class II | Reinforced Dual Lumen Cannula, 13Fr., REF: VV13... | Aug 21, 2018 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.